Clinical Management of Patellar Tendinopathy in Athletes: A Narrative Review of Diagnosis, Treatment, and Return to Sport.
- 1School of Exercise and Health, Shanghai University of Sport, Yangpu, Shanghai 200438, China.
- 2Sports Medicine and Rehabilitation Center, Shanghai University of Sport, Shanghai 200438, China.
- 3Shanghai Shangti Orthopaedic Hospital, Shanghai 200438, China.
Abstract
Patellar tendinopathy affects approximately 18% of athletes and up to 45% of volleyball players, representing a common cause of load-related anterior knee pain and functional limitation in jumping and landing sports. Clinical diagnosis relies primarily on history and physical examination. However, no consensus has yet been established on standardized diagnostic criteria, particularly for imaging-based assessment, and no definitive clinical practice guideline currently exists; imaging abnormalities frequently coexist with symptoms but are also common in asymptomatic athletes, and incidental findings may carry a risk of overdiagnosis and unnecessary imaging-guided management. This narrative review synthesizes the current evidence on the clinical management of patellar tendinopathy in athletes, spanning diagnosis, treatment, long-term prognosis, and return to sport; the literature was identified through structured searches of PubMed, Web of Science, and Google Scholar, with the final search conducted on 1 July 2026. Exercise therapy represents the most extensively studied conservative approach and may be considered a reasonable first-line option, although no single loading mode has demonstrated clear superiority and the underlying evidence is of low to very low certainty; injection strategies differ in mechanisms and evidence strength, but most data come from short-term studies. These studies commonly combine injections with exercise, making the injection's isolated effect unclear. Additionally, shockwave therapy is not supported by current evidence as a first-line or stand-alone option. Because structural imaging changes and clinical symptoms frequently diverge, functional outcomes rather than imaging endpoints should guide load progression and return-to-sport decisions. This review provides clinicians with a practical synthesis of the currently available evidence for treatment selection and patient management, and identifies remaining uncertainties, particularly in adolescent populations and long-term outcome prediction.
Related
- Clinical research advances in pulmonary infections in 2025: a narrative review of multipathogen assessment, precision diagnosis, and integrated management
- Narrative Review: Epidemiology, Pathogenesis, Diagnosis and Clinical Management of Chronic Bronchitis.
- Epidemiology, Clinical Features, and Advances in Diagnosis and Treatment of Chlamydia psittaci Pneumonia: A Narrative Review
- Intranasal teeth: a narrative review of clinical features, diagnosis and management
- Clinical guidelines for the diagnosis and management of pediatric fecal incontinence: A comprehensive review and treatment algorithm
BibTeX
@article{chen2026clinical,
title = {{Clinical Management of Patellar Tendinopathy in Athletes: A Narrative Review of Diagnosis, Treatment, and Return to Sport.}},
author = {Yuhao Chen and Xin Kuang and Xinyan Zheng},
journal = {Healthcare (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/healthcare14193248},
url = {https://europepmc.org/article/MED/42881687},
note = {CC BY},
}
RIS
TY - JOUR
TI - Clinical Management of Patellar Tendinopathy in Athletes: A Narrative Review of Diagnosis, Treatment, and Return to Sport.
AU - Yuhao Chen
AU - Xin Kuang
AU - Xinyan Zheng
PY - 2026
DA - 2026/10/01
JO - Healthcare (Basel, Switzerland)
DO - 10.3390/healthcare14193248
UR - https://europepmc.org/article/MED/42881687
AB - Patellar tendinopathy affects approximately 18% of athletes and up to 45% of volleyball players, representing a common cause of load-related anterior knee pain and functional limitation in jumping and landing sports. Clinical diagnosis relies primarily on history and physical examination. However, no consensus has yet been established on standardized diagnostic criteria, particularly for imaging-based assessment, and no definitive clinical practice guideline currently exists; imaging abnormalities frequently coexist with symptoms but are also common in asymptomatic athletes, and incidental findings may carry a risk of overdiagnosis and unnecessary imaging-guided management. This narrative review synthesizes the current evidence on the clinical management of patellar tendinopathy in athletes, spanning diagnosis, treatment, long-term prognosis, and return to sport; the literature was identified through structured searches of PubMed, Web of Science, and Google Scholar, with the final search conducted on 1 July 2026. Exercise therapy represents the most extensively studied conservative approach and may be considered a reasonable first-line option, although no single loading mode has demonstrated clear superiority and the underlying evidence is of low to very low certainty; injection strategies differ in mechanisms and evidence strength, but most data come from short-term studies. These studies commonly combine injections with exercise, making the injection's isolated effect unclear. Additionally, shockwave therapy is not supported by current evidence as a first-line or stand-alone option. Because structural imaging changes and clinical symptoms frequently diverge, functional outcomes rather than imaging endpoints should guide load progression and return-to-sport decisions. This review provides clinicians with a practical synthesis of the currently available evidence for treatment selection and patient management, and identifies remaining uncertainties, particularly in adolescent populations and long-term outcome prediction.
SN - 2227-9032
ER -